145 related articles for article (PubMed ID: 27977635)
1. Pancreatic Neuroendocrine Tumor Abnormally Secreting Procalcitonin.
Hagiya H; Matsui T; Kitamura T; Inoue T; Shigekawa M; Yoshida H; Morii E; Tomono K
Pancreas; 2017 Jan; 46(1):e7-e9. PubMed ID: 27977635
[No Abstract] [Full Text] [Related]
2. Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.
Giannetta E; Gianfrilli D; Pozza C; Lauretta R; Graziadio C; Sbardella E; Baroli A; Caronna R; Chirletti P; Lenzi A; Isidori AM
Medicine (Baltimore); 2016 Jan; 95(3):e2419. PubMed ID: 26817871
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail.
Machens A; Haedecke J; Hinze R; Thomusch O; Schneyer U; Dralle H
Dig Surg; 2000; 17(5):522-4. PubMed ID: 11124561
[TBL] [Abstract][Full Text] [Related]
4. Alpha-fetoprotein producing pancreatic neuroendocrine tumour.
Wang CY; Lin JC; Li YF; Yang CW
QJM; 2020 Aug; 113(8):565-566. PubMed ID: 31999348
[No Abstract] [Full Text] [Related]
5. [Calcitonin-secreting neuroendocrine carcinoma of the pancreas with splenic invasion and paraneoplastic hypercalcemia].
Kaassis M; Duquenne M; Croué A; Ronceray J; Rohmer V; Bigorgne JC
Presse Med; 2001 Jan; 30(1):24. PubMed ID: 11210583
[No Abstract] [Full Text] [Related]
6. Platelet indices in differential diagnosis of pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Varol E
Eur J Intern Med; 2014 Jul; 25(6):e82. PubMed ID: 24582330
[No Abstract] [Full Text] [Related]
7. Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single institute.
Jun E; Kim SC; Song KB; Hwang DW; Lee JH; Shin SH; Hong SM; Park KM; Lee YJ
Surgery; 2017 Jul; 162(1):120-130. PubMed ID: 28262254
[TBL] [Abstract][Full Text] [Related]
8. Response to: Platelet indices in differential diagnosis of pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Kurt M; Aksoy E
Eur J Intern Med; 2014 Jul; 25(6):e83. PubMed ID: 24873725
[No Abstract] [Full Text] [Related]
9. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
[TBL] [Abstract][Full Text] [Related]
10. Discussion.
Surgery; 2016 Jan; 159(1):347. PubMed ID: 26456129
[No Abstract] [Full Text] [Related]
11. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers.
Patout M; Salaün M; Brunel V; Bota S; Cauliez B; Thiberville L
Clin Biochem; 2014 Dec; 47(18):263-7. PubMed ID: 25218831
[TBL] [Abstract][Full Text] [Related]
12. Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours.
Oberg K
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S17-25. PubMed ID: 22005113
[No Abstract] [Full Text] [Related]
13. Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
Takahashi K; Ozawa E; Nakao K; Aoki S; Takase Y
J Gastroenterol Hepatol; 2019 Jun; 34(6):964. PubMed ID: 30663800
[No Abstract] [Full Text] [Related]
14. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
Ardill JE; O'Dorisio TM
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
[TBL] [Abstract][Full Text] [Related]
15. Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients.
Hilfenhaus G; Göhrig A; Pape UF; Neumann T; Jann H; Zdunek D; Hess G; Stassen JM; Wiedenmann B; Detjen K; Pavel M; Fischer C
Endocr Relat Cancer; 2013 Jun; 20(3):305-19. PubMed ID: 23463017
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors.
Shanahan MA; Salem A; Fisher A; Cho CS; Leverson G; Winslow ER; Weber SM
J Surg Res; 2016 Mar; 201(1):38-43. PubMed ID: 26850182
[TBL] [Abstract][Full Text] [Related]
17. ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature.
Maragliano R; Vanoli A; Albarello L; Milione M; Basturk O; Klimstra DS; Wachtel A; Uccella S; Vicari E; Milesi M; Davì MV; Scarpa A; Sessa F; Capella C; La Rosa S
Am J Surg Pathol; 2015 Mar; 39(3):374-82. PubMed ID: 25353285
[TBL] [Abstract][Full Text] [Related]
18. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive.
Pavel M; Jann H; Prasad V; Drozdov I; Modlin IM; Kidd M
Neuroendocrinology; 2017; 104(2):170-182. PubMed ID: 27078712
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract][Full Text] [Related]
20. Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report.
Kos-Kudła B; Zemczak A; Foltyn W; Marek B; Strzelczyk J; Telega A; Zajecki W; Legaszewski T; Jurecka-Lubieniecka B
Endokrynol Pol; 2007; 58(2):123-9. PubMed ID: 17578828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
